Description |
Rubitecan (RFS 2000), a camptothecin derivative, is an orally active topoisomerase I inhibitor with broad antitumor activity, and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells[1][2][3].
|
Target |
Topoisomerase I[1]
|
In Vitro |
Rubitecan (RFS 2000) inhibits U-CH1, U-CH2, and CCL4 cells with IC50s 0.32, 0.83, and 7.7 µM, respectively[4].
|
Density | 1.6±0.1 g/cm3 |
Boiling Point | 816.3±65.0 °C at 760 mmHg |
Flash Point | 447.5±34.3 °C |
Exact Mass | 393.096100 |
PSA | 127.24000 |
LogP | 1.38 |
Vapour Pressure | 0.0±3.1 mmHg at 25°C |
Storage condition | Room temp |